Toxicologic studies of the 2,4-diamino-quinazoline antifolate, methasquin (NSC-122870).
D000284:Administration, Oral; D000818:Animals; D001773:Blood Cells / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D004285:Dogs; D005260:Female; D005493:Folic Acid Antagonists / Q000633:toxicity; D000882:Haplorhini; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007422:Intestines / Q000187:drug effects; D008251:Macaca; D008297:Male; D008727:Methotrexate / Q000633:toxicity; D051379:Mice; D011799:Quinazolines / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats
D005493:Folic Acid Antagonists; D011799:Quinazolines; D008727:Methotrexate